Visudyne® in Occult (VIO)

Clinical trial NCT00121407 · COMPLETED

Trial details

NCT number: NCT00121407
Sponsor: QLT Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2002-03-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.